Thus, it is possible to associate the increase in serum and urinary eotaxin levels with the development of T2DM complications and renal function impairment, as probably related to obesity that may affect patients with T2DM and favor the low-grade chronic inflammatory process [72, 79]. Here, CCL11 is linked to obesity disorder.